Latest News about REGN
Recent news which mentions REGN
Eaton, Wynn Resorts, Lamar Advertising And This Pharma Company Are CNBC's Final Trades
October 06, 2022
From Benzinga
Apple Short Sellers Made $2B In Profits In September, And Shorts In This Biotech Stock Lost $307M
October 05, 2022
From Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 04, 2022
From Motley Fool
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
What 13 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
Hopeful Golden Cross Forms On Regeneron Pharmaceuticals's Chart
October 03, 2022
Tickers
REGN
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
From Benzinga
Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea
September 27, 2022
From Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
The Top 5 Stocks Cathie Wood Is Buying This Week
September 23, 2022
From InvestorPlace
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
September 20, 2022
Tickers
REGN
From Benzinga
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
From Benzinga
Intellia Therapeutics Posts Back To Back Positive Data From Gene Editing Therapies
September 16, 2022
From Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
Alnylam/Regeneron-Backed NASH Candidate Shows Encouraging Safety Profile In Healthy Volunteers
September 15, 2022
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
From Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
From Benzinga
Regeneron's Bispecific Antibodies Show Encouraging Anti Tumor Activity
September 12, 2022
Tickers
REGN
From Benzinga
9 Analysts Have This to Say About Regeneron Pharmaceuticals
September 09, 2022
Tickers
REGN
From Benzinga
Jefferies Upgrades Regeneron Pharmaceuticals: Here's What You Need To Know
September 09, 2022
Tickers
REGN
From Benzinga
'Highly Compelling' Eye Drug Data Has Wall Street Stampeding To Buy This 'Large Cap Growth Story.' Even After $15B In Market Cap Was Added
September 09, 2022
Tickers
REGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
